Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Published Date: 11 Nov 2025

Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a study published online Oct. 10 in SLEEPJ.

Read Full News

Latest News

Single-dose radiation before surgery can eradicate breast cancer

A single, targeted high dose of radiation delivered before other treatments could completely eradicate tumors in most women with early-stage, operable hormone-positive breast cancer, according to a study led by UT Southwestern ...

Why palliative care goes hand in hand with treatment for people with cancer: Q&A

For many people with cancer and other serious diseases, palliative care is an important element of their journey.

Q&A: Odds of surviving cancer drop drastically when credit score dips

While past studies have explored how cancer patients' financial health influenced their risk of mortality, new research digs in deeper by zeroing in on objective data: credit scores.

Traces of bacteria inside brain tumors may affect tumor behavior

Researchers at The University of Texas MD Anderson Cancer Center have uncovered unexpected traces of bacteria within brain tumors. This discovery offers new insights into the environment in which brain tumors grow and sets ...

Cancer care crowdfunding increasingly common, but rarely successful

A growing number of desperate cancer survivors are turning to crowdfunding to help pay for their treatment and living expenses, a new study says.

Food insecurity linked to tumor growth in pediatric neuroblastoma

Neuroblastoma remains one of the deadliest childhood malignancies, accounting for a disproportionate number of pediatric cancer deaths worldwide.

Todays Updates

Phase 3 VALOR Data Further Support Tofersen’s Impact on ALS Disease Progression, Survival Marco Meglio

Published phase 3 data in JAMA Neurology highlighted tofersen's potential to slow ALS progression and improve survival, marking a breakthrough in SOD1-ALS treatment.

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Todays Updates

Phase 3 VALOR Data Further Support Tofersen’s Impact on ALS Disease Progression, Survival Marco Meglio

Published phase 3 data in JAMA Neurology highlighted tofersen's potential to slow ALS progression and improve survival, marking a breakthrough in SOD1-ALS treatment.

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Adding CBT to Quetiapine Significantly Reduces Suicide Risk in Mood Disorders

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

Iron Polymaltose Complex Outperforms Liposomal Iron in Pediatric CKD Anemia

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Melanoma Surgery Delay After 4 Weeks Post-Diagnosis Decreases Survival Rates

Latest News

A single, targeted high dose of radiation delivered before other treatments could completely eradicate tumors in most women with early-stage, operable hormone-positive breast cancer, according to a study led by UT Southwestern ...

For many people with cancer and other serious diseases, palliative care is an important element of their journey.

While past studies have explored how cancer patients' financial health influenced their risk of mortality, new research digs in deeper by zeroing in on objective data: credit scores.

Researchers at The University of Texas MD Anderson Cancer Center have uncovered unexpected traces of bacteria within brain tumors. This discovery offers new insights into the environment in which brain tumors grow and sets ...

A growing number of desperate cancer survivors are turning to crowdfunding to help pay for their treatment and living expenses, a new study says.

Neuroblastoma remains one of the deadliest childhood malignancies, accounting for a disproportionate number of pediatric cancer deaths worldwide.

News All Time

Study shows supervised exercise improves strength, physical performance in patients with advanced breast cancer

Aerobic and resistance exercise can significantly improve physical performance in patients living with metastatic breast cancer, according to new results presented at the Advanced Breast Cancer Eighth International Consensus ...

Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients

Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia in the Western Hemisphere, affecting approximately 200,000 people in the United States.

Advanced breast cancer patients living longer thanks to improvements in treatment and care

People diagnosed with advanced breast cancer in 2025 can expect to live for an extra six or seven months, compared to the average survival time for patients diagnosed in 2011, according to a major study of patient data in ...

Radiotherapy after mastectomy can be avoided, study finds

Radiotherapy can be safely omitted as a treatment for many breast cancer patients who have had a mastectomy and are taking anti-cancer drugs, a study shows.

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

By analyzing data from three clinical trials treating children with the brain tumor medulloblastoma, scientists at St. Jude Children's Research Hospital have designed an approach to safely reduce therapy, thereby lowering ...

Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of overdiagnosis, or the detection ...

How access to specialized cancer centers affects glioblastoma outcomes

Glioblastoma is one of the most aggressive and complex brain cancers. It grows quickly, resists standard treatments, and often leaves patients and their families searching for every possible option.

Is global cancer care losing its human touch?

A new Lancet Oncology Commission highlights a growing "human crisis" in cancer care. Despite advances in treatment and increased survival rates, many patients worldwide are not receiving the compassionate, holistic support ...

Indoor hydroponic gardening can improve mental health and quality of life for cancer patients

Indoor hydroponic gardening—a method of growing plants using nutrient-rich water instead of soil—could help cancer patients develop better mental health, eat a healthier diet and enjoy a better overall quality of life.

Clinical trial sees dramatic results using radiation to treat breast cancer

Almost immediately after Theresa Greco was diagnosed with breast cancer in March, doctors asked her whether she wanted to participate in a clinical trial. The trial would do high-powered radiation targeted at her tumor prior ...

Dual-action mRNA vaccine takes aim at aggressive skin cancer

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting the protein essential to tumor cell growth and by adding a key signal to boost the immune system response. ...

For incarcerated people, study shows gaps exist in quality of cancer care

In the United States, the incarcerated population is aging. About 15% of incarcerated adults, or approximately 175,000 people, are now 55 years or older.

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

FDA approves Blenrep for relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Radiation therapy for patients with breast cancer

Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.

Study finds higher breast cancer rates in areas with more air pollution

Women living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...

Recommended News For You

For the first time in humans, a chemotherapy drug reaches the brain.

Researchers explore e-bikes for cancer recovery

Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

Using AI, one can find cancer risk factors.

Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

Recommended Articles For You

The Benefits and Side Effects of Bortezomib in the Fight Against Cancer  

Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates 

Cowden Syndrome and Cancer: Understanding the Risk Factors  

Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Hospitalization and mortality rates are associated with exposure to the omicron variant of COVID-19 in patients with solid cancer.

2.

Because of the Medicare mail-order drug rule, oncologists run the risk of self-referral violations.

3.

Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting

4.

Francis Collins reveals that he was diagnosed with "aggressive" prostate cancer.

5.

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

1.

Exploring the Mysteries of MGUS: Uncovering the Causes and Treatments

2.

The Latest Research on Wiskott Aldrich Syndrome 

3.

Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies

4.

Unlocking The Power Of Cangrelor To Treat Heart Disease

5.

A Visual Journey Through Penile Cancer: Examining the Impact of Photos

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

2.

Efficient Management of First line ALK-rearranged NSCLC - Part II

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

4.

Virtual Case Study on Deep Vein Thrombosis (DVT) - An Initiative by Hidoc Dr.

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot